Dulaglutide
Dulaglutide (Trulicity) is a once-weekly GLP-1 injection for type 2 diabetes that also lowers heart attack and stroke risk. Dosing and side effects.
About Dulaglutide
Dulaglutide is a glp-1 receptor agonist also known by the brand name Trulicity. It is primarily used for Type 2 diabetes in adults and children 10 years and older, with diet and exercise and Lowering the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes who have heart disease or several cardiovascular risk factors (Trulicity label). Dulaglutide is available in trulicity single-dose prefilled pens: 0.75 mg, 1.5 mg, 3 mg and 4.5 mg, each in 0.5 ml, the needle is hidden and already attached; each pen is used once and discarded, and store in the refrigerator; a pen may be kept at room temperature (below 86°f) for up to 14 days in total form. Healthcare providers commonly prescribe Dulaglutide for conditions including Diabetes Mellitus, Coronary Artery Disease (CAD), and Obesity.
Dulaglutide at a Glance
- Brand names
- Trulicity
- Drug class
- GLP-1 Receptor Agonist
- Pregnancy category
- Use in pregnancy only if the potential benefit justifies the potential risk to the baby; there is limited human data, and animal studies showed harm. Tell your clinician if you are pregnant or planning a pregnancy, because blood sugar control still matters and other treatments such as insulin are usually preferred. It is not known whether dulaglutide passes into breast milk.
- Available forms
- Trulicity single-dose prefilled pens: 0.75 mg, 1.5 mg, 3 mg and 4.5 mg, each in 0.5 mL, The needle is hidden and already attached; each pen is used once and discarded, Store in the refrigerator; a pen may be kept at room temperature (below 86°F) for up to 14 days in total
- Therapeutic categories
- Diabetes, GLP-1 Agonists, Endocrine
- Conditions treated
- 3 related conditions on this site
What Dulaglutide Is Used For
- Type 2 diabetes in adults and children 10 years and older, with diet and exercise
- Lowering the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes who have heart disease or several cardiovascular risk factors (Trulicity label)
Dosage Quick Reference
These are general dosage guidelines for Dulaglutide. Your doctor will determine the appropriate dose for your specific situation.
| Step | Weekly Dose | When to Move Up |
|---|---|---|
| Start (adults and children 10 and older) | 0.75 mg under the skin once weekly | After 4 weeks, if more blood sugar control is needed |
| Step 2 | 1.5 mg once weekly (the maximum dose for children) | After at least 4 weeks |
| Step 3 (adults) | 3 mg once weekly | After at least 4 weeks |
| Maximum (adults) | 4.5 mg once weekly | Highest recommended dose |
| Missed dose | Take it if at least 3 days (72 hours) remain before the next scheduled dose | If fewer than 3 days remain, skip it and take the next dose on schedule |
Side Effects
Common side effects may include:
• Nausea, especially in the first weeks and after a dose increase • Diarrhea • Vomiting • Abdominal pain • Decreased appetite • Indigestion • Fatigue
Serious side effects (seek immediate medical attention):
• Severe stomach pain that may spread to the back, with or without vomiting (possible pancreatitis) • Pain in the upper right abdomen, fever or yellow skin or eyes (possible gallbladder disease) • A lump or swelling in the neck, trouble swallowing or persistent hoarseness • Ongoing vomiting or diarrhea with dizziness or little urine (dehydration and kidney injury) • Swelling of the face, lips or throat, or trouble breathing (allergic reaction) • Changes in vision • Low blood sugar when taken with insulin or a sulfonylurea
See also: Drug Interactions ↓
Drug Interactions
Dulaglutide is broken down like other proteins and does not rely on CYP450 liver enzymes. Its interactions come from slowed stomach emptying and from added blood sugar lowering.
- Insulin and sulfonylureas (for example glipizide): Higher risk of low blood sugar. The insulin or sulfonylurea dose is often lowered when dulaglutide starts.
- Oral medicines with a narrow safety margin (for example warfarin): Slower stomach emptying can change how quickly pills are absorbed; extra monitoring may be needed after starting or changing the dose.
- Other GLP-1 medicines (for example semaglutide, liraglutide or tirzepatide): Not used together.
- DPP-4 inhibitors (for example sitagliptin): Work through the same hormone system and add little benefit, so they are usually stopped.
- Alcohol: Can worsen nausea and raise the risk of low blood sugar in people on insulin or a sulfonylurea.
See also: Questions to Ask Your Doctor ↓
Key Considerations
Known drug interactions
Dulaglutide has documented interactions with other medications, supplements, and certain foods. Review the Drug Interactions section below and tell your healthcare provider about every medication you take, including over-the-counter products. Jump to section →
Multiple forms available
Dulaglutide comes in more than one form (Trulicity single-dose prefilled pens: 0.75 mg, 1.5 mg, 3 mg and 4.5 mg, each in 0.5 mL, The needle is hidden and already attached; each pen is used once and discarded, Store in the refrigerator; a pen may be kept at room temperature (below 86°F) for up to 14 days in total). The right form for you depends on your condition, ease of use, and your provider's recommendation.
Additional Information
Dulaglutide is a once-weekly injection sold as Trulicity. FDA approved it in 2014 for type 2 diabetes, and it later became one of the GLP-1 medicines proven to lower the risk of heart attack and stroke. It is given with a single-use pen that hides the needle, which made it a popular first injectable for people who were nervous about shots. It is approved for diabetes only; it is not a weight loss medicine, although many people lose a modest amount of weight while taking it.
How Dulaglutide Works
Dulaglutide copies the action of GLP-1, a gut hormone released after meals. It helps the pancreas release insulin when blood sugar is high, lowers glucagon (a hormone that raises blood sugar), slows stomach emptying and reduces appetite. Because the insulin effect depends on glucose, dulaglutide rarely causes low blood sugar when used on its own or with metformin.
The medicine is a GLP-1 molecule fused to part of a human antibody. That larger structure protects it from being broken down quickly, giving it a half-life of about five days, so one dose lasts a week.
FDA-Approved Uses
Type 2 Diabetes in Adults and Children
Dulaglutide is approved, alongside diet and exercise, to improve blood sugar in adults and in children 10 years and older with type 2 diabetes. It can be used alone or with metformin, SGLT2 inhibitors such as empagliflozin, sulfonylureas and insulin. In the trials behind its approval, the 0.75 mg and 1.5 mg doses lowered A1c by roughly 0.7 to 1.6 percentage points, depending on the starting A1c and the other medicines being taken. It is not used for type 1 diabetes.
Lowering Heart Attack and Stroke Risk
In 2020, FDA added an indication to reduce major cardiovascular events in adults with type 2 diabetes who have established heart disease or multiple cardiovascular risk factors. The approval was based on the REWIND trial, published in The Lancet, which followed about 9,900 adults for a median of 5.4 years. Heart attack, stroke or cardiovascular death occurred about 12 percent less often with dulaglutide than with placebo. Most participants did not have a prior heart attack or stroke, which is why the label covers people at high risk as well as those with known coronary artery disease.
Dosing and How to Take It
Everyone starts at 0.75 mg once a week. After four weeks, the dose can go up to 1.5 mg if blood sugar is still above goal. Adults who need more can move to 3 mg and then 4.5 mg, staying at least four weeks at each step, as described in the Trulicity label. For children, 1.5 mg is the highest dose.
Inject it on the same day each week, at any time of day, with or without food, into the abdomen, thigh or upper arm, and rotate the site. If you miss a dose and at least three days remain before the next one, take it. If fewer than three days remain, skip it and return to your regular day.
Unopened pens belong in the refrigerator. A pen can stay at room temperature for up to 14 days in total, which helps with travel, but it should never be frozen.
Side Effects
Stomach symptoms are the most common. In placebo-controlled trials, about one in five people on the 1.5 mg dose had nausea, and about one in eight had diarrhea or vomiting. These effects are usually mild to moderate, appear in the first weeks, and ease as the body adjusts. Eating smaller meals, stopping when full and limiting greasy food help. Our guide to managing GLP-1 side effects has more practical tips.
Boxed Warning and Serious Risks
Dulaglutide carries a boxed warning for thyroid C-cell tumors, based on rodent studies; whether it causes these tumors in people is unknown. It is not used by anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2).
Other serious risks listed on the label include pancreatitis, gallbladder disease, kidney injury from dehydration after vomiting or diarrhea, severe allergic reactions and worsening of diabetic eye disease in people who already have retinopathy. It is not recommended for people with severe gastroparesis. Because it slows stomach emptying, tell your surgeon or anesthesiologist that you take it before any procedure with sedation.
Dulaglutide Compared With Newer GLP-1 Medicines
Dulaglutide was once the most prescribed GLP-1 medicine in the United States. Newer options generally lower A1c and weight more. In head-to-head studies, semaglutide (Ozempic) lowered A1c and weight more than dulaglutide at comparable dose levels, and tirzepatide (Mounjaro) more still. The higher 3 mg and 4.5 mg doses of dulaglutide, added in 2020, narrowed that gap somewhat.
Dulaglutide still has real strengths: a proven heart benefit, no dose change needed for kidney disease, an easy pen, and a long safety record. For someone whose diabetes is well controlled on it and who tolerates it, there is often no reason to switch. If weight loss is a main goal, or A1c stays above target at the highest dose, we talk about moving to another medicine in the class.
Monitoring and Follow-Up
We check A1c about every three months until it is at goal, then every six months, along with kidney function and cholesterol at our in-office lab. If you take insulin or a sulfonylurea, we review home glucose readings closely in the first weeks, since those doses often need to come down. People with diabetic retinopathy should stay current with dilated eye exams, especially when blood sugar improves quickly.
Getting Started in St. Petersburg
Dulaglutide is one of several GLP-1 options we prescribe for type 2 diabetes. Our physicians choose among them based on your A1c, heart and kidney health, weight goals and insurance coverage, and our GLP-1 medication program explains how the choices compare. To review your diabetes treatment, schedule a visit.
Frequently Asked Questions
Questions to Ask Your Doctor About Dulaglutide
Consider discussing these topics at your next appointment:
- Is dulaglutide still the best GLP-1 choice for me, or would a newer option fit my goals better?
- What A1c are we aiming for, and when would we raise the dose?
- Should my insulin or sulfonylurea dose be lowered when I start?
- Do I need a dilated eye exam before my blood sugar comes down quickly?
- What should I do about dulaglutide before surgery or a colonoscopy?
Questions About Dulaglutide?
Your primary care doctor in St. Petersburg can review Dulaglutide alongside everything else you take, check for interactions, and adjust your plan as your health changes.
Request an appointmentMedical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.